Results 51 to 60 of about 73,048 (297)

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker, Kyle Kemp, Perri Tutelman, Sharon H. J. Hou, Paul Fairie, Maria Santana, Gregory M. T. Guilcher, Taryn Fay‐McClymont, Glenda Bendiak, Wendy Pelletier, Nicola Wright, Fiona Schulte   +11 more
wiley   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa, Shou Xu, Mark Zobeck, Sarah E. Sartain, Nino Rainusso, Lisa Wang, Nicole Montgomery, Paige Wheaton, Sarah Whittle   +8 more
wiley   +1 more source

Somatic Symptom Severity (PHQ-15) and Emotion Regulation (ERQ)

, 2022
How are somatic symptom severity and the two ways of emotion regulation, suppression and reappraisal ...
Ulrike Beck
core   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli, Seth Rotz, Masatoshi Takagi, Richa Sharma   +3 more
wiley   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Somatic Symptom Disorder

, 2022
Somatic symptom disorder is diagnosed when an individual presents with one or more physical symptoms (such as pain, weakness or shortness of breath) that are distressing or cause disruption in daily life.
Cheema, Fauzia, Paracha, Hamza, Qayyum, Zheala, Zeshan, Muhammad, Chaudhary, Amna Mohyuddin, Arain, Fauzia, Abbas, Sakina, Mansoor, Iqtidar   +7 more
core  

Effects of the Fluid Replacement Method During Online Hemodiafiltration on the Solute Removal Performance and Biocompatibility Using the Asymmetric Cellulose Triacetate Membrane

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Pre‐dilution online hemodiafiltration (Pre‐HDF) is predominantly used in Japan, whereas post‐dilution online HDF (Post‐HDF) is more common in Europe. An asymmetric cellulose triacetate (ATA) membrane may improve biocompatibility.
Kenji Sakurai, Yoshitaka Kurihara, Fumi Yamauchi, Hiromi Hosoya, Takeshi Saito   +4 more
wiley   +1 more source

Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder and functional somatic syndromes: EURONET-SOMA recommendations [PDF]

, 2017
Objective: The harmonization of core outcome domains in clinical trials facilitates comparison and pooling of data, and simplifies the preparation and review of research projects, and comparison of risks and benefits of treatments.
Henningsen, Peter, Peter Henningsen, Rief, W, Rosmalen, J., Frostholm, L., Loewe, Bernd, Kleinstaeuber, Maria, Burton, C., Martin, A, Shedden-Mora, M, Schröder, A., Löwe, B, Ulrik Malt, Malt, U., Kop, W.J., Schröder, A, Meike Shedden-Mora, Rosmalen, Judith; id_orcid, van der Feltz-Cornelis, Christina, Martin, Alexandria, Shedden-Mora, M., Kop, WJ, Toussaint, A., Winfried Rief, Chris Burton, Alexandra Martin, Judith Rosmalen, Kleinstäuber, Maria, Kop, Willem J., van der Feltz-Cornelis, C.M., Toussaint, Anne, Frostholm, Lisbeth, Anne Toussaint, Malt, U, Andreas Schröder, van der Feltz-Cornelis, C., Rief, Winfried, Maria Kleinstäuber, Löwe, B., Henningsen, P, Toussaint, A, Willem J. Kop, Christina van der Feltz-Cornelis, Lisbeth Frostholm, Henningsen, P., Kleinstäuber, M., Malt, Ulrik, Schroder, Andreas, Bernd Löwe, Löwe, Bernd, Rosmalen, J, van der Feltz-Cornelis, C, Burton, C, Martin, A., Frostholm, L, EURONET-SOMA Group, Rosmalen, Judith, Shedden-Mora, Meike, Rief, W., Martin, Alexandra, Burton, Chris   +60 more
core   +1 more source

Somatic Symptom and Related Disorders in Children and Adolescents

, 2022
Somatic Symptom and Related Disorder (SSRD) comprise a group of disorders characterized by the prominence of persistent physical symptoms associated with significant stress and impairment.
Rask, Charlotte U., Hulgaard, Ditte Roth; id_orcid, Ibeziako, Patricia, Tsang, Kevin   +3 more
core   +1 more source

Organ‐specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides

FEBS Letters, EarlyView.
We identified a systemic, progressive loss of protein S‐glutathionylation—detected by nonreducing western blotting—alongside dysregulation of glutathione‐cycle enzymes in both neuronal and peripheral tissues of Taiwanese SMA mice. These alterations were partially rescued by SMN antisense oligonucleotide therapy, revealing persistent redox imbalance as ...
Sofia Vrettou, Brunhilde Wirth
wiley   +1 more source